Qualitative Interviews of Physicians Managing Patients With Methamphetamine‐Associated Pulmonary Arterial Hypertension: Understanding the Unmet Medical Needs From a Provider Lens

Ähnliche Einträge

• Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial Hypertension
  von: Hilary M. DuBrock, et al.
  Veröffentlicht: (2025)
• Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research
  von: Jean M. Elwing, et al.
  Veröffentlicht: (2025)
• Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase‐5 Inhibitors (PDE5i)
  von: Nicholas A. Kolaitis, et al.
  Veröffentlicht: (2025)
• A Systematic Literature Review Exploring the Efficacy and Safety of Tadalafil and Sildenafil in Pulmonary Arterial Hypertension
  von: Rajan Saggar, et al.
  Veröffentlicht: (2025)
• Methamphetamine‐Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management
  von: Namita Sood, et al.
  Veröffentlicht: (2026)